April 01, 2019
Endo Pharmaceuticals Inc. is decrying the disqualification of BakerHostetler from bellwether cases in the multidistrict opioid litigation, asserting that an Ohio federal judge "effectively became a witness" against the law firm during disqualification proceedings.
March 20, 2019
An Ohio federal judge on Wednesday disqualified BakerHostetler from two bellwether cases in the multidistrict opioid litigation, citing confidential information that a firm partner viewed while working at the U.S. Department of Justice.
February 25, 2019
An Ohio federal judge on Monday carved out Ohio cities from the first bellwether cases in multidistrict litigation over the opioid epidemic and indefinitely postponed their trial date.
February 19, 2019
A prominent plaintiffs attorney in the opioid multidistrict litigation has been accused of misconduct after denouncing the family that owns OxyContin maker Purdue Pharma LP as "scumbags" akin to "Mexican cartels," Law360 has learned.
February 06, 2019
The Ohio federal judge supervising multidistrict litigation over the opioid crisis said Wednesday that he may disqualify a BakerHostetler attorney on conflict-of-interest grounds and cited the dust-up as a vindication of his original push for a settlement of the epic MDL.
January 30, 2019
A federal judge Wednesday denied Purdue Pharma LP's bid in multidistrict litigation over the country's opioid epidemic to either delay or prevent the release of still-redacted allegations in a state court suit brought by the Massachusetts attorney general, but the company is still fighting a state court order at issue.
January 29, 2019
An Ohio federal judge agreed Tuesday to once again push back the start date of the first bellwether trial in multidistrict litigation over the country's opioid epidemic to give the plaintiffs and the opioid makers enough time to resolve ongoing discovery issues.
January 29, 2019
The city of Cleveland has filed a redacted motion in Ohio federal court laying out its reasons for seeking to disqualify a BakerHostetler partner and former U.S. attorney from representing Endo Pharmaceuticals Inc. in a bellwether case over the opioid epidemic, saying that in a deposition she used confidential information she gained while she was a public official.
January 23, 2019
Endo Pharmaceuticals Inc. on Wednesday hit back at a motion to disqualify a BakerHostetler partner— and former U.S. attorney who worked on the opioid crisis— from bellwether cases in the opioid multidistrict litigation, saying she hasn't violated any ethical rule.
January 18, 2019
An Ohio federal judge on Friday blocked drug distributors from trying again to keep racketeering allegations out of a bellwether trial in the opioid multidistrict litigation, rejecting assertions that enormous damages associated with racketeering will hinder settlement talks.